Webinar Recap: The Future of Standardized Herbal Extracts and Bioavailability Enhancement

Over 1,800 global R&D directors, brand founders, and formulation chemists gathered for our live technical symposium dissecting HPLC standardization, liposomal delivery systems, and clean-label excipients. Discover our contract manufacturing solutions or read related articles on our nutraceutical blog.

1,800+
Attendees
On-Demand
Available

Key Discussions & Takeaways

The nutraceutical landscape is undergoing an unprecedented shift toward clinical transparency. Consumers and regulatory bodies are no longer satisfied with generic botanical powders; they demand standardized marker compounds, verified pharmacokinetic absorption, and documented batch stability.

During this intensive 90-minute panel, our lead R&D scientists together with international pharmacognosy consultants addressed formulation strategies to overcome botanical bioavailability barriers.

Core Discussion Topics

• Liposomal and Self-Emulsifying Drug Delivery (SEDDS): Methods to formulate curcuminoids, CoQ10, and ashwagandha with up to 10x higher cellular uptake.
• Eliminating Synthetic Excipients: Replacing magnesium stearate, silicon dioxide, and titanium dioxide with clean-label rice hull extracts and bamboo silica.
• Global Cross-Border Compliance (US, EU, UK): Navigating novel food rules and health claim substantiation protocols for new botanical entities.